Covidien Unveils the Next Generation in Advanced SurgeryLigaSure Advance(TM) Instrument for Laparoscopic Procedures

BOULDER, Colo.--(HSMN NewsFeed)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that its Energy-based Devices business unit has introduced LigaSure Advance™, the first multifunctional laparoscopic instrument that offers surgeons fingertip control of both tissue fusion and monopolar dissection.
LigaSure Advance™ was created in response to what surgeons said they need to optimize efficiency and safety in the operating room. This latest innovation in the LigaSure™ lineup is a 5 mm hand-activated instrument that provides surgeons with the ability to create fusion cycles in two to four seconds, and when used with Valleylab™ mode, the unique energy modality delivers dissection and hemostasis.With sterile-field control of mode and power settings, LigaSure Advance™ is designed to enable surgeons and perioperative staff to focus more effectively on the procedure and patient. Its versatility reduces the need for instrument exchanges, making procedures more efficient and potentially reducing overall operating time.

full article >> http://salesandmarketingnetwork.com/news_release.php?ID=2024124